1-6 of 6
Jeevan Kumar
Close
Sort by
Journal Articles

Safety and Efficacy of Bortezomib-Pomalidomide-Dexamethasone (VPD) As Novel Induction Therapy in Newly-Diagnosed Multiple Myeloma: Updated Data from an Ongoing Single Arm Phase-II Investigator- Initiated Clinical Trial (PRIME Study)

Jeevan Kumar, Rajat Pincha, Vivek S Radhakrishnan, Naveed Tamboli, Arijit Nag, Dibakar Podder, Debranjani Chattopadhyay, Saurabh Jayant Bhave, Sreya Das, Mayur Parihar, Asish Rath, Sushant Vinarkar, Sumit Mukhopadhyay, Subhosmito Chakraborty, Deepak Kumar Mishra, Mammen Chandy, Reena Nair
Journal: Blood
Blood (2023) 142 (Supplement 1): 6713.
https://doi.org/10.1182/blood-2023-186903
Published: 2023
Journal Articles

Bortezomib-Pomalidomide-Dexamethasone (VPD) As Novel Induction Therapy in Newly-Diagnosed Multiple Myeloma: Early Safety Data from an Ongoing Single Arm Phase-II Investigator-Initiated Clinical Trial (PRIME Study)

Vivek S Radhakrishnan, Naveed Tamboli, Shreya Das, Jeevan Kumar Garg, Arijit Nag, Saurabh J Bhave, Mayur Parihar, Sushant Vinarkar, Sumit Mukhopadhyay, Subhosmito Chakraborty, Deepak K Mishra, Reena Nair, Mammen Chandy
Journal: Blood
Blood (2021) 138 (Supplement 1): 2752.
https://doi.org/10.1182/blood-2021-151718
Published: 2021
Journal Articles

Induction Mortality in Acute Myeloid Leukemia: A 9 Year Retrospective Study from a Tertiary Care Centre in a Low-Middle Income Country Setting

Vivek S Radhakrishnan, Sandeep A Pattnaik, Arunima Bhadhuri, Vasundhara Raina, Payal Mandal, Saurabh J Bhave, Jeevan Kumar Garg, Arijit Nag, Sushant Vinarkar, Mayur Parihar, Deepak K Mishra, Reena Nair, Mammen Chandy
Journal: Blood
Blood (2021) 138 (Supplement 1): 4388.
https://doi.org/10.1182/blood-2021-154152
Published: 2021
Journal Articles

Adolescent and Young Adult Hodgkin Lymphoma: Is More Better?

Reghu K Sukumaran Nair, MDDCH DM PDF, Vivek S Radhakrishnan, MDDM MSc PDF, Avijeet K Mishra, MBBS MD, Vinay A Guntiboina, MD, Saurabh J Bhave, MDPDF, Jeevan Kumar Garg, MDDNB PDF, Indu Arun, MDPDF, Lateef Zameer, MD, Debdeep Dey, MDFRCPath, Neeraj Arora, MDPDF, Deepak K Mishra, MDPDF, Arpita Bhattacharyya, MRCP, Niharendu Ghara, MDDCH FRCPath, Rimpa B Achari, MD, Shekhar Krishnan, MRCP FRCPath PhD, Mammen Chandy, MDFRCP FRACP FRCPA, Reena Nair, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-142276
Published: 2020
Journal Articles

Cachexia at Diagnosis adversely predicts outcomes in patients with Aggressive B-Cell NHL receiving standard of care treatment: A Prospective Observational Study from India

Vivek S Radhakrishnan, MDDM,MSc, Reena Nair, MD, Anwesha Patra, Saurabh Jayant Bhave, MD, Jeevan Kumar Garg, MDDNB, Mohandas Mallath, MDDNB
Journal: Blood
Blood (2019) 134 (Supplement_1): 2907.
https://doi.org/10.1182/blood-2019-126295
Published: 2019
Journal Articles

Clinical Characteristics and Treatment Outcome of Acute Myeloid Leukemia with APL-like Morphology and Uncommon RARA Fusion Variants

Oussama Abla, MD, Laura Cicconi, Pau Montesinos, MD PhD, Eduardo Magalhães Rego, MDPhD, Anthony P Schwarer, MD MBBS (Hons), FRACP, FRCPA, Elihu H. Estey, MD, Anna Maria Testi, MD, Jordi Esteve, MD, Ombretta Annibali, Alessandra Scardocci, MD, Roberto Castelli, MD, Vladimir Lazarevic, MD PhD, Franco Locatelli, MD PhD, Jeevan Kumar, MD, Miguel A. Sanz, MD, Francesco Lo Coco, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3860.
https://doi.org/10.1182/blood.V130.Suppl_1.3860.3860
Published: 2017